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Abstract
Background: Hepatitis B infection is a global threat for people of all age groups and is common in Bangladesh and other South Asian countries. Blood 
donors and blood donation can present important risk for hepatitis B infection. Our objective was to identify seroprevalence of hepatitis B virus among 
blood donors in Faridpur, Bangladesh. Methods: A cross-sectional study was conducted among 719 blood donors in the Faridpur district of Bangladesh from 
April to July 2013. Data was collected by non-probability convenient sampling maintaining inclusion and exclusion criteria. Face-to-face interview, blood 
grouping test, and hepatitis B surface antigen (HBsAg) screening were conducted. Results: About 30% of the blood donors were between 19 and 23 years 
of age, and 87.5% of them were males. Two-thirds (64.1%) of the donors were replacement donors, while the remaining 35.9% of them were voluntary 
donors. The overall seropositivity of HBsAg was found to be 1.5%. All infected blood donors were males. Hepatitis B infection was more prevalent in the 
34–38 years age group and least prevalent among those older than 48 years of age. About 2% of replacement blood donors were infected with hepatitis B 
virus, compared to 0.7% among voluntary blood donors. Conclusion: Hepatitis B infection among blood donors is relatively lower than in other high-risk 
groups for hepatitis B infection in Bangladesh. Predominance of HBsAg among older adult groups, replacement donors, and the male gender can be a 
matter of public health concern.
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Introduction
Hepatitis B virus (HBV) is a small DNA virus that belongs to 
the Hepadna virus family and infects nearly 240 million people 
worldwide. HBV infection is transmitted mostly during infancy 
and childhood, even though people of all age groups are equa-
lly affected.1 The prevalence rate of HBV infection in Bangla-
desh is in the same magnitude as the Indian Subcontinent and 
Middle East at 2–5% (Available from: http://www.who.int/me-
diacentre/factsheets/fs204/en, updated 2015 Mar; cited 2015 
May 24), although a much higher hepatitis B surface antigen 
(HBsAg) positivity (5.5%) has been reported among the general 
population of Savar, a semi-urban area located near the capital 
of Bangladesh.2 The lifetime risk of acquiring HBV infection in 
the mentioned areas is 20–60%, with about 40% of the world 
population residing in the said regions.1
Viral liver diseases are significant causes of morbidity in Ban-
gladesh, and a large proportion of acute viral hepatitis, chronic 
liver disease, hepatocellular carcinoma, and post transfusion 
hepatitis cases in Bangladesh could be attributed to HBV in-
fections.3 Early detection is necessary to reduce the risk and 
impact of viral liver diseases. A number of diagnostic tests 
could be performed to detect the presence of HBV in the blood. 
While antibody to the hepatitis B core antigen (anti-HBc) is an 
important biomarker in the detection of HBV infection, HBsAg 
is the most trustworthy biological biomarker of HBV.4 Most of 
the previous studies in Bangladesh have used HBsAg as the 
biomarker.5-8 
Various studies have been conducted among the known major 
high-risk groups to examine the prevalence of the life-threate-
ning HBV infection in Bangladesh, but the prevalence of HBV 
infection in the general population has received little atten-
tion.5-17 To estimate the prevalence of HBsAg among the ge-
neral population, we conducted a study among the first-time 
blood donors at two voluntary blood donation organizations in 
Faridpur, Bangladesh. Specifically, the aims of the study were 
to determine the overall seroprevalence of HBV among blood 
donors and to identify the prevalence of HBsAg among different 
age groups, genders, blood groups, and donor types.
Methods
Study Setting and Participants
A cross-sectional study of first-time blood donors was conduc-
ted at two voluntary blood donation agencies in Faridpur, Ban-
gladesh with approval from the Faridpur Medical College Hospi-
tal. These two voluntary blood donation agencies were the local 
branches of the respective national agencies and handled most 
of the blood donation in Faridpur. Males and females between 
the ages of 18 years and 65 years were eligible to donate blood, 
with an average donation amount of 350 ml as stipulated in 
national guidelines. We collected data on demographic varia-
bles such as age and sex, blood group, type of donation, and 
serological screening results from April 1, 2013 to July 31, 2013.
Replacement donors (family members, friends, or relatives 
of the patients whom the blood would be donated to) and 
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voluntary blood donors (people who donated blood without 
expecting any favor in return or in voluntary blood donation 
camps) of both genders who donated blood in the defined time 
period went through blood screening procedures, and inclusion 
and exclusion criteria were applied to select participants for 
the study. Specifically, the inclusion criteria were: (1) donating 
blood for the first time, having no previous record or history of 
donation; (2) normal findings on general physical examination; 
(3) mentally capable; and (4) provided informed consent for
blood donation and participation in the study. Exclusion criteria
were same as those for blood donation: (1) not within the age
limit eligible for blood donation; (2) a pulse rate of more than
120/min, as blood donation might be risky; (3) a systolic blood
pressure higher than 180 mmHg, as blood donation might be
risky; (4) having clinical symptoms of anemia; (5) any history
of surgery or dental treatment within the last six months; (6)
blood transfusion within the last six months; (7) women du-
ring menstruation, not suitable due to blood loss; (8) alcohol
consumption within the last 72 hours, as serum alcohol level
might be significant; and (9) any known history of exposure
to hepatitis B. The flow of participants through the study is
presented in Figure 1.
Sampling Technique and Sample Size
Respondents were selected through non-probability convenient 
sampling. All donors who attended the two agencies in the 
defined period who met the inclusion criteria were included af-
ter considering the exclusion criteria. For calculation of sample 
size, we used a prevalence figure of 50% (which would genera-
te the biggest sample size with the same a piori criteria), as no 
recent studies had been conducted within the last three years 
or in regions with similar settings to our study area. Using 
the equation for minimum sample size estimation of single 
proportion, n=Z2pq/d2 , where z=1.96, p=0.5, q=1-p=0.5, d=0.05, 
the minimum sample size required was 384.16 (rounded to 
384). We used a sample size of 719 to account for the possible 
non-responses. 
Data Collection
Face-to-face interviews were conducted with the participants 
for about 10 minutes by experts using questionnaires to collect 
information about their personal status, eligibility, and some 
demographic variables including age, sex, religion, residential 
area, and any relationship with the patient to whom the blood 
was donated to. The questionnaire was approved by a profes-
sor of public health from Faridpur Medical College. Questions 
related to inclusion and exclusion criteria were asked for selec-
tion purpose. Pulse rates were measured by experts, and blood 
pressures were measured three times with the average calcu-
lated to minimize measurement errors. Then blood grouping 
was done to confirm their blood group. After proper aseptic 
measures, blood was collected from the middle cubital vein 
and kept in a test tube at -20°C for preservation.
Serological Screening 
At room temperature, the test tubes with blood samples were 
centrifuged at 3,000 rotations per minute for 8–10 minutes, and 
clear plasma was collected from the upper part of the fluid for 
screening. To examine the presence of HBsAg in the blood, HB-
sAg test strip and serum/plasma kits (Atlas Medical, UK), which 
were rapid chromatographic immunoassays for the qualitative 
detection of HBsAg in human serum/plasma, were used. If test 
result was positive, the test was repeated once for confirma-
tion purpose. The test was done by a medical technician and 
was approved by a physician. The blood samples were mar-
ked in a unique manner to prevent mistakes and biases. Data 
pertaining to the patients were given the same identification 
number as of their blood samples to minimize errors. 
Data Management
Data management and screening was done by master tabula-
tion. Simple descriptive analyses were done using Microsoft 
Excel 2010. Data was then imported into IBM SPSS Statistics for 
Windows version 18 (IBM Corp., Armonk, New York, USA) for 
further analyses. The analysis was approved by a statistician. 
Ethical Measures
Informed consent was obtained from the participants after the 
rationale and aim of the study as well as their ability to wi-
thdraw from participation voluntarily were explained. Proper 
privacy and confidentiality was maintained throughout the pro-
cess. The research protocol was approved by the local ethical 
committee of Faridpur. The STrengthening of Reporting of OB-
servational studies in Epidemiology (STROBE) was followed in 
preparing this paper.18
Results
Table 1 shows the characteristics of the 719 blood donors who par-
ticipated in our study. Young donors between 19 and 23 years of 
age accounted for the largest proportion (29.5%) of the participa-
ting donors. The vast majority of donors (87.5%) were males. Most 
Figure 1. Selection of Participants for the Study
Total number of donors who visited the 
selected agencies within study period 
(n=955)
Excluded (n=236)
Not meeting inclusion criteria (n=151)
– Not first-time donor (n=98)
– Abnormal general examination findings (n=27)
– Consent not provided (n=26)
Meeting exclusion criteria (n=85)
– Not within age limit (n=6)
– Pulse rate >120/min (n=4)
– Systolic blood pressure >180 mmHg (n=14)
– Anemic (n=32)
– History of surgery or dental extraction within last 6
months (n=4)
– Blood transfusion within last 6 months (n=5)
– Menstruation (n=18)
– Alcohol consumption within last 3 days (n=2)
Total number of final participants 
(n=719)
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(88.8%) of the donors were from the region/district in which the 
two voluntary blood donation organizations were located. Volun-
tary donors constituted 35.9% of all donors, while the remaining 
64.1% were replacement donors.
The blood group composition of the donors was as follows: 173 
(24.1%) were A positive, 283 (39.3%) were B positive, 174 (24.2%) 
were O positive, 63 (8.8%) were AB positive, and the remaining 26 
(3.6%) were of rhesus-negative groups. The proportions of volun-
tary donors among A positive donors, B positive donors, O positive 
donors, and rhesus-negative donors were 51.1%, 27.2%, 38.9%, 
and 50.0%, respectively. 
Among all the screened blood samples, 11 (1.5%) blood donors 
were HBsAg-positive. All HBsAg-positive donors were male. The 
seroprevalence of HBsAg among different blood groups was as 
follows: 1.7% in A positive donors, 0.7% in B positive donors, and 
2.3% among O positive donors. Seroprevalence of HBsAg in diffe-
rent age groups is shown in Figure 2. HBV prevalence were 1.9% 
among the replacement donors and 0.7% among the voluntary 
donors.
Discussion
The main purpose of our study was to determine the preva-
lence of HBV infection among first-time blood donors in Fari-
dpur, Bangladesh. The result revealed a HBsAg seropositivity of 
1.5% among all first-time donors, similar to findings from pre-
vious studies conducted among blood donors in Khulna and in 
Rangamati, Bangladesh, which estimated a prevalence of 1.1–
1.4%.19,20 In contrast, previous studies among high-risk groups 
of transfusion-transmitted infections (TTIs) in Bangladesh re-
ported higher prevalences of HBV infection, ranging from 3.8% 
to 9.7%.1,9,11,17,21-23 The prevalence of HBV infection among blood 
donors in our study was similar with those reported by studies 
conducted in nearby countries (India, Pakistan, and China) in 
2013.24-26 In comparison, the worldwide seroprevalence of HB-
sAg is 3.6%.27
In our study, we found that HBV infection was more common 
among donors between 34 and 38 years of age. This might 
be due to known high-risk behaviors among this age group, 
including history of previous blood transfusions, occupational 
or accidental injuries, and higher frequency of sexual beha-
viors. A recent study in a country adjacent to Bangladesh—Ne-
pal—showed that TTIs were more common among those aged 
between 21 and 30 years.28 One possible explanation for the 
difference could be that the Nepal study included all TTIs, while 
our study focused on hepatitis B infection. Nonetheless, both 
our study and the Nepal study found that hepatitis B infection 
was more prevalent among males. B positive donors consti-
tuted the biggest group of donors, but the seroprevalence of 
HBV infection was higher among O positive donors and A po-
sitive donors, although the differences were not statistically 
significant. HBV infection was also more common among re-
placement donors (1.9%) than voluntary donors (0.7%). More 
studies are required to examine the reasons for these findings.
In this study, we also captured sociodemographic backgrounds 
of all blood donors. Our results showed that young age groups 
(of 19 to 23 years) were more enthusiastic in blood donation, 
concurring with previous findings.1,29-31 Additionally, the vast 
majority of the donors were males. This could possibly be at-
tributed to the fact that in Bangladesh, females are more occu-
pied with household works and hence have less time for blood 
donation. This finding is supported by a study in a neighboring 
country with similar socioeconomic condition.28
The study had some limitations. As this is a cross-sectional 
study, risk factors and natural histories of HBV infection among 
participating donors could not be determined. We are aware 
that our study, conducted in a small community/area, might 
not be representative of a larger community/area. Nonetheless, 
we were able to assess the distribution of different variables 
such as age, sex, blood groups, and type of blood donation and 
Donor characteristics
Number of donors 
(N=719)
Percentage (%)
Age (years)
<19 28 3.9
19–23 212 29.5
24–28 152 21.1
29–33 109 15.2
34–38 69 9.6
39–43 85 11.8
44–48 39 5.4
>48 25 3.5
Gender
Male 629 87.5
Female 90 12.5
Marital status
Single 224 31.1
Married 495 68.9
Place of living
Same district 638 88.8
Outside the district 81 11.2
Religion
Muslim 630 87.6
Hindu 88 12.3
Christian 1 0.1
Type of donor
Voluntary 258 35.9
Replacement 461 64.1
Blood group
A+ 173 24.1
B+ 283 39.3
O+ 174 24.2
AB+ 63 8.8
Others (rhesus negative) 26 3.6
HBsAg result
Positive 11 1.5
Negative 708 98.5
Table 1. Characteristics of Blood Donors in Faridpur, Bangladesh
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In conclusion, the prevalence of HBV infection among blood 
donors in Faridpur, Bangladesh is not negligible. The rate was 
similar to those reported in other regions of Bangladesh, which 
vary between 1.1% and 1.6%. HBsAg positivity of blood donors 
in Bangladesh was slightly greater than those of India, Nepal, 
and China but lower than that in Pakistan. The proportion of HBV 
infection in blood donors was much lower than other high-risk 
groups reported in Bangladesh. In view of these findings, we 
recommend that proper screening measures for HBsAg and 
other TTIs should be practiced before blood donations. People 
from all eligible age groups and genders should be encouraged 
to donate blood, while risk factors for TTIs should be effectively 
assessed and prevented. Infected blood donors should be in-
formed, managed, and treated promptly. Appropriate policies 
should be implemented to ensure the safety of blood donation 
and blood transfusions, for example, through public awareness 
campaigns. More research studies are needed to examine the 
risk factors, epidemiological features, trends, and preventive 
measures for HBV infection in Bangladesh.
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